Safety assessment and determination of a maximally tolerated dose of an RAS-GTPase inhibitor (iRAS) in the treatment of gastrointestinal tumors: preliminary results of the phase I trial - PDF (俄语)
版权所有 © Bozhenko V.K., Goncharov S.V., Kudinova E.A., Kulinich T.M., Kukoleva E.A., Filippov M.S., Bykova A.F., Knyazeva O.B., Puchkov I.A., Solodkiy V.A., 2023
此作品已接受知识共享署名-非商业性使用 4.0国际许可协议的许可。